Logo image of JXJT

JX Luxventure Ltd (JXJT) Stock Fundamental Analysis

NASDAQ:JXJT - MHY460023028 - Common Stock

0.8075 USD
-0.02 (-2.96%)
Last: 12/19/2024, 8:00:02 PM
0.8 USD
-0.01 (-0.93%)
After Hours: 12/19/2024, 8:00:02 PM
Fundamental Rating

3

Overall JXJT gets a fundamental rating of 3 out of 10. We evaluated JXJT against 50 industry peers in the Textiles, Apparel & Luxury Goods industry. While JXJT is still in line with the averages on profitability rating, there are concerns on its financial health. JXJT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

JXJT had positive earnings in the past year.
JXJT had a positive operating cash flow in the past year.
In the past 5 years JXJT reported 4 times negative net income.
JXJT had a negative operating cash flow in each of the past 5 years.
JXJT Yearly Net Income VS EBIT VS OCF VS FCFJXJT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M -60M

1.2 Ratios

The Return On Assets of JXJT (22.90%) is better than 96.00% of its industry peers.
The Return On Equity of JXJT (33.51%) is better than 90.00% of its industry peers.
The Return On Invested Capital of JXJT (25.61%) is better than 94.00% of its industry peers.
Industry RankSector Rank
ROA 22.9%
ROE 33.51%
ROIC 25.61%
ROA(3y)-178.22%
ROA(5y)-108.78%
ROE(3y)-232.62%
ROE(5y)-141.69%
ROIC(3y)N/A
ROIC(5y)N/A
JXJT Yearly ROA, ROE, ROICJXJT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400

1.3 Margins

The Profit Margin of JXJT (9.90%) is better than 86.00% of its industry peers.
JXJT's Operating Margin of 9.91% is fine compared to the rest of the industry. JXJT outperforms 72.00% of its industry peers.
JXJT has a worse Gross Margin (16.34%) than 92.00% of its industry peers.
In the last couple of years the Gross Margin of JXJT has grown nicely.
Industry RankSector Rank
OM 9.91%
PM (TTM) 9.9%
GM 16.34%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.54%
GM growth 5YN/A
JXJT Yearly Profit, Operating, Gross MarginsJXJT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300 -400

More info and screens

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), JXJT is creating value.
Compared to 1 year ago, JXJT has less shares outstanding
JXJT has more shares outstanding than it did 5 years ago.
There is no outstanding debt for JXJT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
JXJT Yearly Shares OutstandingJXJT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
JXJT Yearly Total Debt VS Total AssetsJXJT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of -0.59, we must say that JXJT is in the distress zone and has some risk of bankruptcy.
JXJT has a Altman-Z score of -0.59. This is amonst the worse of the industry: JXJT underperforms 86.00% of its industry peers.
JXJT has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.03, JXJT is doing good in the industry, outperforming 78.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -0.59
ROIC/WACC3.4
WACC7.54%
JXJT Yearly LT Debt VS Equity VS FCFJXJT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M 100M

2.3 Liquidity

JXJT has a Current Ratio of 0.59. This is a bad value and indicates that JXJT is not financially healthy enough and could expect problems in meeting its short term obligations.
JXJT's Current ratio of 0.59 is on the low side compared to the rest of the industry. JXJT is outperformed by 98.00% of its industry peers.
A Quick Ratio of 0.59 indicates that JXJT may have some problems paying its short term obligations.
With a Quick ratio value of 0.59, JXJT is not doing good in the industry: 94.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.59
Quick Ratio 0.59
JXJT Yearly Current Assets VS Current LiabilitesJXJT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 102.15% over the past year.
Looking at the last year, JXJT shows a very negative growth in Revenue. The Revenue has decreased by -40.80% in the last year.
Measured over the past years, JXJT shows a quite strong growth in Revenue. The Revenue has been growing by 11.42% on average per year.
EPS 1Y (TTM)102.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.74%
Revenue 1Y (TTM)-40.8%
Revenue growth 3Y187.49%
Revenue growth 5Y11.42%
Sales Q2Q%30.9%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
JXJT Yearly Revenue VS EstimatesJXJT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 0.87, which indicates a rather cheap valuation of JXJT.
Compared to the rest of the industry, the Price/Earnings ratio of JXJT indicates a rather cheap valuation: JXJT is cheaper than 100.00% of the companies listed in the same industry.
JXJT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.24.
Industry RankSector Rank
PE 0.87
Fwd PE N/A
JXJT Price Earnings VS Forward Price EarningsJXJT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, JXJT is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 0.61
JXJT Per share dataJXJT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

JXJT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

JX Luxventure Ltd

NASDAQ:JXJT (12/19/2024, 8:00:02 PM)

After market: 0.8 -0.01 (-0.93%)

0.8075

-0.02 (-2.96%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)08-16 2023-08-16
Earnings (Next)N/A N/A
Inst Owners0%
Inst Owner Change0%
Ins Owners6.04%
Ins Owner ChangeN/A
Market Cap4.89M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.87
Fwd PE N/A
P/S 0.08
P/FCF N/A
P/OCF 0.51
P/B 0.28
P/tB N/A
EV/EBITDA 0.61
EPS(TTM)0.93
EY115.17%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.39
FCFYN/A
OCF(TTM)1.58
OCFY195.51%
SpS9.9
BVpS2.93
TBVpS-0.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 22.9%
ROE 33.51%
ROCE 33.55%
ROIC 25.61%
ROICexc 26.9%
ROICexgc N/A
OM 9.91%
PM (TTM) 9.9%
GM 16.34%
FCFM N/A
ROA(3y)-178.22%
ROA(5y)-108.78%
ROE(3y)-232.62%
ROE(5y)-141.69%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.54%
GM growth 5YN/A
F-Score6
Asset Turnover2.31
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA 0.09
Cap/Depr 1836.39%
Cap/Sales 19.84%
Interest Coverage 250
Cash Conversion 145.04%
Profit Quality N/A
Current Ratio 0.59
Quick Ratio 0.59
Altman-Z -0.59
F-Score6
WACC7.54%
ROIC/WACC3.4
Cap/Depr(3y)145.67%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.05%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)102.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.74%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-40.8%
Revenue growth 3Y187.49%
Revenue growth 5Y11.42%
Sales Q2Q%30.9%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y111.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y78.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y226.55%
OCF growth 3YN/A
OCF growth 5YN/A